Vor Biopharma Inc.

VOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 Dec 19, 2025
3 Dec 19, 2025
SCHEDULE 13G Dec 19, 2025
SCHEDULE 13D/A Dec 18, 2025
8-K Dec 18, 2025 8-K
SCHEDULE 13G Dec 17, 2025
4 Dec 9, 2025
4 Dec 9, 2025
4 Dec 9, 2025
8-K Dec 9, 2025 8-K
424B3 Dec 1, 2025 424B3
SCHEDULE 13G Nov 18, 2025
SCHEDULE 13D/A Nov 14, 2025
10-Q Nov 13, 2025 10-Q
8-K Nov 12, 2025 8-K
424B5 Nov 12, 2025 424B5
424B5 Nov 10, 2025 424B5
S-3/A Nov 10, 2025 S-3/A
SCHEDULE 13G Nov 7, 2025
SCHEDULE 13G Nov 5, 2025
8-K Nov 3, 2025 8-K
SCHEDULE 13D/A Oct 30, 2025
4 Oct 30, 2025
8-K Oct 28, 2025 8-K
SCHEDULE 13D/A Oct 27, 2025
← Newer Page 4 of 19 · 463 filings Older →